REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy.
- DOI
- 10.1161/circheartfailure.123.011548
- Published
- 2024 Jul
- Container
- Circulation. Heart failure
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/circheartfailure.123.011548,
title = {REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy.},
author = {Garcia-Pavia P and Palomares JFR and Sinagra G and Barriales-Villa R and Lakdawala NK and Gottlieb RL and Goldberg RI and Elliott P and Lee P and Li H and Angeli FS and Judge DP and MacRae CA and REALM-DCM Investigators},
year = {2024},
journal = {Circulation. Heart failure},
doi = {10.1161/circheartfailure.123.011548},
url = {https://doi.org/10.1161/circheartfailure.123.011548}
}RIS
TY - JOUR TI - REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy. AU - Garcia-Pavia P AU - Palomares JFR AU - Sinagra G AU - Barriales-Villa R AU - Lakdawala NK AU - Gottlieb RL AU - Goldberg RI AU - Elliott P AU - Lee P AU - Li H AU - Angeli FS AU - Judge DP AU - MacRae CA AU - REALM-DCM Investigators PY - 2024 JO - Circulation. Heart failure DO - 10.1161/circheartfailure.123.011548 UR - https://doi.org/10.1161/circheartfailure.123.011548 ER -
APA
P, G., JFR, P., G, S., R, B., NK, L., RL, G., RI, G., P, E., P, L., H, L., FS, A., DP, J., CA, M., & Investigators, R. (2024). REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy.. Circulation. Heart failure. https://doi.org/10.1161/circheartfailure.123.011548
Source records
- pubmed · retrieved 2026-09-26T13:13:40.241Z